Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Ruxolitinib treatment may cause eyelash growth.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Many adult women suffer from persistent or late-onset acne, and while various treatments exist, finding the right one can be challenging.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

Secondary amenorrhea has many causes and requires thorough evaluation to treat and restore menstrual cycles.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Doctors should recognize and treat PCOS early in primary care to manage symptoms and lower risk of other health issues.

PCOS is managed with medication, lifestyle changes, and a healthy diet.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Acne keloidalis nuchae causes scarring on the scalp, mainly in African American males, and early treatment is important to prevent lasting damage.

Herbal supplements like Berberine, Cinnamon, and Fenugreek may be affordable alternatives for managing PCOS.

Pharmacists play a crucial role in patient care and public health.

Baricitinib may effectively treat oral lichen planus.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Samcyprone ointment is effective for treating common warts if a sensitization reaction occurs first.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

MicroRNAs are crucial in controlling cell signaling, affecting cancer and tissue regeneration.